GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Basilea Pharmaceutica AG Allschwil BSLN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

72.20

+1.69%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

10 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 4Buy
  • 2Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 72.20Average target 99.96

Low
69.69
Average
99.96
Median
107.10
High
126.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueCHF 281.5mCHF 299.7mCHF 257.4mCHF 190.6mCHF 189.4m
Revenue, highestCHF 302.0mCHF 345.0mCHF 268.5mCHF 204.5mCHF 203.2m
Revenue, lowestCHF 268.1mCHF 271.6mCHF 246.3mCHF 181.5mCHF 180.4m
Earnings per share5.734.582.23-0.830.65
Earnings per share, highest6.377.284.26-0.780.71
Earnings per share, lowest5.172.250.20-0.910.61
Analysts15211

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q4 2025Q2 2025Q4 2024Q2 2024Q1 2024Q4 2023
Forecast3.311.641.933.300.96-2.00-2.05
Reported2.111.541.264.221.61-1.78-1.56
Difference-36.3%-6.1%-34.6%+27.7%+67.9%+11.1%+23.7%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 16.0% a year over 10 years. Return on equity 31.4%.

Model fair value

51.13

From earnings 51.13, from revenue 52.57.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.